dc.contributor.author | Strohecker, A M | |
dc.contributor.author | Joshi, S | |
dc.contributor.author | Abraham, R T | |
dc.contributor.author | White, E | |
dc.contributor.author | Possemato, Richard | |
dc.contributor.author | Sabatini, David | |
dc.date.accessioned | 2017-01-30T16:04:02Z | |
dc.date.available | 2017-01-30T16:04:02Z | |
dc.date.issued | 2015-03 | |
dc.date.submitted | 2015-01 | |
dc.identifier.issn | 0950-9232 | |
dc.identifier.issn | 1476-5594 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/106673 | |
dc.description.abstract | Deregulation of autophagy has been linked to multiple degenerative diseases and cancer, thus the identification of novel autophagy regulators for potential therapeutic intervention is important. To meet this need, we developed a high content image-based short hairpin RNA screen monitoring levels of the autophagy substrate p62/SQSTM1. We identified 186 genes whose loss caused p62 accumulation indicative of autophagy blockade, and 67 genes whose loss enhanced p62 elimination indicative of autophagy stimulation. One putative autophagy stimulator, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 (PFKFB4), drives flux through pentose phosphate pathway. Knockdown of PFKFB4 in prostate cancer cells increased p62 and reactive oxygen species (ROS), but surprisingly increased autophagic flux. Addition of the ROS scavenger N-acetyl cysteine prevented p62 accumulation in PFKFB4-depleted cells, suggesting that the upregulation of p62 and autophagy was a response to oxidative stress caused by PFKFB4 elimination. Thus, PFKFB4 suppresses oxidative stress and p62 accumulation, without which autophagy is stimulated likely as a ROS detoxification response. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (Grants R37 CA53370, RC1 CA147961, R01 CA163591, and R01 CA130893) | en_US |
dc.description.sponsorship | Rutgers Cancer Institute of New Jersey (Grant P30 CA072720) | en_US |
dc.description.sponsorship | Johnson & Johnson | en_US |
dc.description.sponsorship | Pfizer Inc. | en_US |
dc.language.iso | en_US | |
dc.publisher | Nature Publishing Group | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1038/onc.2015.23 | en_US |
dc.rights | Creative Commons Attribution-Noncommercial-Share Alike | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | en_US |
dc.source | PMC | en_US |
dc.title | Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel autophagy regulator by high content shRNA screening | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Strohecker, A M et al. “Identification of 6-Phosphofructo-2-Kinase/fructose-2,6-Bisphosphatase as a Novel Autophagy Regulator by High Content shRNA Screening.” Oncogene 34.45 (2015): 5662–5676. | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biology | en_US |
dc.contributor.department | Whitehead Institute for Biomedical Research | en_US |
dc.contributor.mitauthor | Possemato, Richard | |
dc.contributor.mitauthor | Sabatini, David | |
dc.relation.journal | Oncogene | en_US |
dc.eprint.version | Author's final manuscript | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Strohecker, A M; Joshi, S; Possemato, R; Abraham, R T; Sabatini, D M; White, E | en_US |
dspace.embargo.terms | N | en_US |
dc.identifier.orcid | https://orcid.org/0000-0002-2401-0030 | |
dc.identifier.orcid | https://orcid.org/0000-0002-1446-7256 | |
mit.license | OPEN_ACCESS_POLICY | en_US |